Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
287
datasets available to search
ShareScore release 0.9.0
Dataset results
287 results for “respiratory syncytial virus”
Importance of respiratory syncytial virus as a predictor of hospital length of stay in Bronchiolitis
<p>DATA BASE OF ARTICLE TITTLED "<strong>Importance of respiratory syncytial virus as a predictor of hospital length of stay in Bronchiolitis"</strong></p>
Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers
ClinicalTrials.gov study NCT04491877. IPD Sharing: YES. Countries: 3. Publications: 1.
Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of
ClinicalTrials.gov study NCT05437510. IPD Sharing: YES. Countries: 3. Publications: 2.
Importance of respiratory syncytial virus as a predictor of hospital length of stay in Bronchiolitis
<p>Database paper </p>
Datasets, scripts and log files to PHIRST respiratory syncytial virus analysis (South Africa, 2017-2018)
No description provided.
Fatal enhanced respiratory syncytial virus disease in toddlers
<p>In 1967, two toddlers immunized with a formalin-inactivated vaccine against respiratory syncytial virus (FIRSV) in the United States died from enhanced RSV disease (ERD), a severe form of illness resulting from aberrant priming of the antiviral immune response during vaccination. Up to 80% of immunized children subsequently exposed to wild-type virus were hospitalized. These events hampered RSV vaccine development for decades. In this manuscript, we provide a characterization of the clinical, immunopathological, and transcriptional signature of fatal human ERD, outlining novel evidence for safety evaluation of RSV vaccines and a framework for understanding disease enhancement for pathogens in general. These are the scanned histology slides from this study. </p>
Supplementary Materials for Respiratory Syncytial Virus Genetic Diversity and Lineage Changes in Ireland pre- and post-COVID-19 pandemic
<p><span>The datasets presented here are the list of publicly available reference sequences used in NextClade (</span><a href="https://github.com/rsv-lineages"><span>https://github.com/rsv-lineages</span></a><span>) to provide the lineage classification of samples and used as reference for analysis of Irish RSV sequences (Supplementary Table 1), the list of sequenced Human respiratory syncytial viruses (RSV) in the Republic of Ireland during the period 2015-2024 (Supplementary Table 2) and the details of sequences downloaded from GISAID corresponding to European RSV sequences for the same period of time.</span></p> <p><span> </span></p> <p><span>Description of the data and file structure</span></p> <p><span>The files in this dataset were formatted in Microsoft Excel 2019 to allow easy access and manipulation of the data. The data corresponds to details on the sequences used in the analysis of RSV in Europe during the 2015-2024 period. The contents of the files are described below: -<strong>Supplementary Table 1</strong>: NextClade Reference Sequences publicly available at </span><a href="https://github.com/rsv-lineages"><span>https://github.com/rsv-lineages</span></a><span>. -<strong>Supplementary Table 2</strong>: Irish RSV Sequence Details contains details on the sequences generated in our study with the GenBank accession number, the GISAID accession number, reported collection RSV season, Nextclade assigned taxonomical clade. -<strong><span>Supplementary Table 3</span></strong>: European RSV Sequence Details contains a list of European RSV sequences downloaded from GISAID (</span><a href="https://gisaid.org/"><span>https://gisaid.org/</span></a><span>) with details on the sampling RSV season, the accession number, country of collection, and lineage assigned by NextClade.</span></p> <p><span> </span></p> <p><span>Sharing/Access information</span></p> <p><span>The databases used to extract and deposit the data were:</span></p> <p><span>-GenBank: the North American repository of sequences and publicly available at: </span><a href="https://www.ncbi.nlm.nih.gov/genbank/"><strong><span>https://www.ncbi.nlm.nih.gov/genbank/</span></strong></a><span> </span></p> <p><span>-GISAID:International consortium of sequences with some metadata and clinical data. It is a semi-public repository with easy access requiring only to create an account. Available at: </span><a href="https://gisaid.org/"><strong><span>https://gisaid.org/</span></strong></a></p> <p><span>-Github: reference sequences of RSV are available at the repository </span><a href="https://github.com/"><strong><span>https://github.com/</span></strong></a></p>
Pandemic, epidemic, endemic: B cell repertoire analysis reveals unique anti-viral responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus
<p>VDJ gene usage, and associated amino acid sequences and properties, from healthy controls as well as patients with COVID-19, RSV or Ebola and Yellow fever vaccine recipients.</p>
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24
ClinicalTrials.gov study NCT03606512. IPD Sharing: Not stated. Countries: 8. Publications: 1.
A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults
ClinicalTrials.gov study NCT02115815. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women
ClinicalTrials.gov study NCT02753413. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age
ClinicalTrials.gov study NCT05330975. IPD Sharing: NO. Countries: 1. Publications: 2.
The Development of a Human Model of Respiratory Syncytial Virus Infection
ClinicalTrials.gov study NCT01349543. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV
ClinicalTrials.gov study NCT03339713. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults
ClinicalTrials.gov study NCT03814590. IPD Sharing: YES. Countries: 2. Publications: 1.
Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection
ClinicalTrials.gov study NCT03656510. IPD Sharing: Not stated. Countries: 22. Publications: 1.
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
ClinicalTrials.gov study NCT00129766. IPD Sharing: Not stated. Countries: 24. Publications: 1.
Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their In
ClinicalTrials.gov study NCT04126213. IPD Sharing: YES. Countries: 9. Publications: 1.
A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, W
ClinicalTrials.gov study NCT02956837. IPD Sharing: YES. Countries: 4. Publications: 2.
Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)
ClinicalTrials.gov study NCT04938830. IPD Sharing: YES. Countries: 27. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.